Bob Mauch's leadership at Cencora focuses on digital transformation, talent development, and growth-oriented investments to ...

Novo Nordisk will hold an Extraordinary General Meeting to elect new board members due to a disagreement with the Foundation ...

Sanofi's Tzield gains FDA's expedited review, promising rapid access to innovative treatment for type 1 diabetes and ...

Galapagos announced plans to scale back on its cell therapy business, while the company pursues new transformational business ...

The MFN pricing approach, while politically attractive, raises complex questions about how to fairly and sustainably price ...

Kenvue opposes a Citizen Petition to change Tylenol's pregnancy warning, citing lack of scientific evidence for claims ...

In light of the recent Congressional Budget Office report highlighting the impact of lower National Institutes of Health ...

The adoption of artificial intelligence (AI) has accelerated, yet its impact on R&D productivity remains underwhelming.

Peptilogics Founder and CEO, Jonathan Steckbeck noted that advances in peptide design and safety have positioned the field to ...

In today’s Pharmaceutical Executive Daily, we cover the FDA’s creation of a new National Priority Voucher Program, the market ...

Pharmaceutical Executive: What impact will TrumpRx and other DTC programs have on drug availability? Jesse Mendelsohn: To be ...